Epirubicin: A Review of its Efficacy as Adjuvant Therapy and in the Treatment of Metastatic Disease in Breast Cancer

Author： Ormrod D.   Holm K.   Goa K.   Spencer C.  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.15, Iss.5, 1999-11, pp. : 389-416

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Docetaxel: A Pharmacoeconomic Review of its Use in the Treatment of Metastatic Breast Cancer

By Lamb H.M.   Wiseman L.R.  

PharmacoEconomics, Vol. 14, Iss. 4, 1998-10 ,pp. : 447-459

Adis International

Access to resources Recommend Favorite

Fulvestrant: A Review of its Use in Hormone Receptor-Positive Metastatic Breast Cancer in Postmenopausal Women with Disease Progression following Antiestrogen Therapy

By McKeage K.   Curran M.P.   Plosker G.L.  

Drugs, Vol. 64, Iss. 6, 2004-01 ,pp. : 633-648

Adis International

Access to resources Recommend Favorite

Docetaxel: A Review of its Use in Metastatic Breast Cancer

By Lyseng-Williamson Katherine A.   Fenton Caroline  

Drugs, Vol. 65, Iss. 17, 2005-01 ,pp. : 2513-2531

Adis International

Access to resources Recommend Favorite

Bevacizumab: A Review of its Use in Combination with Paclitaxel or Capecitabine as First-Line Therapy for HER2-Negative Metastatic Breast Cancer

By Croom Katherine F.   Dhillon Sohita  

Drugs, Vol. 71, Iss. 16, 2011-11 ,pp. : 2213-2229

Adis International

Access to resources Recommend Favorite

Trastuzumab: A Review of its Use in the Treatment of Metastatic Breast Cancer Overexpressing HER2

By McKeage K.   Perry C.M.  

Drugs, Vol. 62, Iss. 1, 2002-01 ,pp. : 209-243

Adis International

Access to resources Recommend Favorite